Literature DB >> 8709632

Cytogenetic findings in acute biphenotypic leukaemia.

F Carbonell1, J Swansbury, T Min, E Matutes, N Farahat, V Buccheri, R Morilla, L Secker-Walker, D Catovsky.   

Abstract

We have studied the immunological and cytogenetic features of 26 patients with acute leukaemia classified as biphenotypic according to a scoring system based on the number and lineage specificity of antigens expressed on the blast cells. The series included 19 adults (age >15 years) and seven children. The cases were distributed in four immunophenotypic groups: (1)coexpression of myeloid and B antigens, 18 cases (69 percent);(2)myeloid and T cell antigens, six (23 percent); (3) one case with trilineage differentiation; and (4) one case with coexpression of both B and T cell antigens. Cytogenetic analysis revealed a normal karyotype in four cases (15 percent) and abnormal clones in 22 (85 percent). Eight patients had the Philadelphia (Ph) translocation, t(9;22)(q34;q11), (31 percent), three cases had structural aberrations of 6q and two had 11q23 rearrangements, one with t(11;19) and a second with t(4;11); the other eight cases had different alterations including t(9;12)(q1;q1), t(8;21)(q22;q22), t(2;7) (p1?3;q3?4), t(7;12)(q11;p11), hyperdiploidy and other structural abnormalities. The chromosomal rearrangements in children were characterised by abnormalities of 11q23 in two cases and the Ph translocation in three. Our data indicate that biphenotypic features are common in cases presenting with t(9;22) as the eight cases included here represent 47 percent of all cases of Ph+ve acute leukaemia studied in our Institution. Biphenotypic acute leukaemias comprise a heterogeneous group of leukaemias involving pluripotent stem cells. Cytogenetic studies are essential in characterising these cases as they will disclose several poor prognosis chromosome aberrations of which the Ph chromosome is the most frequent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8709632

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  18 in total

Review 1.  Clinical applications of BCR-ABL molecular testing in acute leukemia.

Authors:  Amgad L Nashed; Kathleen W Rao; Margaret L Gulley
Journal:  J Mol Diagn       Date:  2003-05       Impact factor: 5.568

2.  Development of five dual-color, double-fusion fluorescence in situ hybridization assays for the detection of common MLL translocation partners.

Authors:  Jeannette G Keefe; William R Sukov; Ryan A Knudson; Lai P Nguyen; Cynthia Williamson; Jason P Sinnwell; Rhett P Ketterling
Journal:  J Mol Diagn       Date:  2010-06-10       Impact factor: 5.568

3.  B-Lymphoid and myeloid lineages biphenotypic acute leukemia with t(8;21)(q22;q22).

Authors:  Guangsheng He; Depei Wu; Aining Sun; Yongquan Xue; Zhengming Jin; Huiying Qiu; Xiaowen Tang; Miao Miao; Zhengzheng Fu; Xiao Ma; Xiuli Wang; Zixin Chen; Changgeng Ruan
Journal:  Int J Hematol       Date:  2008-02-22       Impact factor: 2.490

4.  Multilineage involvement of light microscopic myeloperoxidase-negative acute leukemia.

Authors:  Toyotaka Iguchi; Yuko Yamada; Norihiro Awaya; Yasuo Ikeda; Shinichiro Okamoto; Masahiro Kizaki
Journal:  Int J Hematol       Date:  2005-11       Impact factor: 2.490

5.  MLL-ENL cooperates with SCF to transform primary avian multipotent cells.

Authors:  Cathleen E Schulte; Marieke von Lindern; Peter Steinlein; Hartmut Beug; Leanne M Wiedemann
Journal:  EMBO J       Date:  2002-08-15       Impact factor: 11.598

6.  Clinical and biological characteristics of adult biphenotypic acute leukemia in comparison with that of acute myeloid leukemia and acute lymphoblastic leukemia: a case series of a Chinese population.

Authors:  Xiao-Qian Xu; Jian-Min Wang; Shu-Qing Lü; Li Chen; Jian-Min Yang; Wei-Ping Zhang; Xian-Min Song; Jun Hou; Xiong Ni; Hui-Ying Qiu
Journal:  Haematologica       Date:  2009-05-19       Impact factor: 9.941

7.  Acute mixed lineage leukemia in children: the experience of St Jude Children's Research Hospital.

Authors:  Jeffrey E Rubnitz; Mihaela Onciu; Stanley Pounds; Sheila Shurtleff; Xueyuan Cao; Susana C Raimondi; Frederick G Behm; Dario Campana; Bassem I Razzouk; Raul C Ribeiro; James R Downing; Ching-Hon Pui
Journal:  Blood       Date:  2009-01-08       Impact factor: 22.113

8.  Monosomies 7p and 12p and FLT3 internal tandem duplication: possible markers for diagnosis of T/myeloid biphenotypic acute leukemia and its clonal evolution.

Authors:  Yosuke Matsumoto; Tomohiko Taki; Yoshiko Fujimoto; Kyoko Taniguchi; Daisuke Shimizu; Kazuho Shimura; Hitoji Uchiyama; Junya Kuroda; Kenichi Nomura; Tohru Inaba; Chihiro Shimazaki; Shigeo Horiike; Masafumi Taniwaki
Journal:  Int J Hematol       Date:  2009-03-24       Impact factor: 2.490

9.  Aleukemic leukemia cutis in a patient with Philadelphia chromosome-positive biphenotypic leukemia.

Authors:  Masahiro Onozawa; Satoshi Hashino; Hiroe Kanamori; Koh Izumiyama; Masakatsu Yonezumi; Koji Chiba; Takeshi Kondo; Takashi Fukuhara; Junji Tanaka; Masahiro Imamura; Masahiro Asaka
Journal:  Int J Hematol       Date:  2004-10       Impact factor: 2.490

Review 10.  Targeting Immunophenotypic Markers on Leukemic Stem Cells: How Lessons from Current Approaches and Advances in the Leukemia Stem Cell (LSC) Model Can Inform Better Strategies for Treating Acute Myeloid Leukemia (AML).

Authors:  Kelly Mitchell; Ulrich Steidl
Journal:  Cold Spring Harb Perspect Med       Date:  2020-01-02       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.